LILLE COVID RESEARCH NETWORK (Covid-19)

计划入组 757 人 · 首次发布于 2020 年 7 月 17 日

Observatory of the Lille Paediatric Allergy Unit

计划入组 1,000 人 · 首次发布于 2024 年 10 月 10 日

Prevalence of COVID-19 Infection Among HCW in a French University Hospital

计划入组 900 人 · 首次发布于 2020 年 5 月 1 日

ALIPD-55

Targeted LGALS9 monoclonal antibody (University of Lille)

N-substituted amino-benzamides (Auburn University/University of Alabama)

DELPHARM Lille SAS

France

Institut Pasteur De Lille

Belgium

CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE

France

Breakthrough Brain Infusion Therapy Shows Promise in Advanced Parkinson's Disease Treatment

InBrain Pharma Secures €1.8 Million to Industrialize Anaerobic Dopamine Production for Advanced Parkinson's Disease

BioVersys Receives EMA Orphan Designation for Novel Tuberculosis Combination Therapy